Contracts › 75N93025F00001
75N93025F00001: A Phase 1 Trial to Evaluate an Orally Ingested Probiotic Yeast Genetically Modified to Express a Tetra-Specific Anti-Toxin for Clostridioides Difficile
Awarded to Icon Government and Public Health Solutions, Inc. by National Institutes of Health (NIH).
$2.5Mobligated
$2.5Mpotential value
21 September 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93025F00001 |
|---|---|
| Vehicle | 75N93022D00018 |
| Awardee | Icon Government and Public Health Solutions, Inc. |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | PA |
| Offers received | 1 |
| Period of performance | 14 January 2022 to 21 September 2028 |
| Potential end | 21 September 2028 |
| Estimated recompete solicitation | ~Q1 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record